[1]
Han C, Someya S. Mouse models of age-related mitochondrial neurosensory hearing loss. Mol Cell Neurosci 2013; 55: 95-100.
[2]
Gates GA, Mills JH. Presbycusis. Lancet 2005; 366: 1111-20.
[3]
Zytsar MV, Barashkov NA, Bady-Khoo MS, et al. Updated carrier rates for c.35delG (GJB2) associated with hearing loss in Russia and common c.35delG haplotypes in Siberia. BMC Med Genet 2018; 19: 138.
[4]
Chan DK, Chang KW. GJB2-associated hearing loss: Systematic review of worldwide prevalence, genotype, and auditory phenotype. Laryngoscope 2014; 124: E34-53.
[5]
Wu L, Li R, Chen J, et al. Analysis of mitochondrial A1555G mutation in infants with hearing impairment. Exp Ther Med 2018; 15: 5307-13.
[6]
Ding Y, Leng J, Fan F, et al. The role of mitochondrial DNA mutations in hearing loss. Biochem Genet 2013; 51: 588-602.
[7]
Young WY, Zhao L, Qian Y, et al. Extremely low penetrance of hearing loss in four Chinese families with the mitochondrial 12S rRNA A1555G mutation. Biochem Biophys Res Commun 2005; 328: 1244-51.
[8]
Chen J, Yang L, Yang A, et al. Maternally inherited aminoglycoside-induced and nonsyndromic hearing loss is associated with the 12S rRNA C1494T mutation in three Han Chinese pedigrees. Gene 2007; 401: 4-11.
[9]
Zheng J, Ji Y, Guan MX. Mitochondrial tRNA mutations associated with deafness. Mitochondrion 2012; 12: 406-13.
[10]
Hoptasz M, Szczuciński A, Losy J. Heterogeneous phenotypic manifestations of maternally inherited deafness associated with the mitochondrial A3243G mutation. Case report. Neurol Neurochir Pol 2014; 48: 150-3.
[11]
Chen DY, Zhu WD, Chai YC, et al. Mutation in PCDH15 may modify the phenotypic expression of the 7511T>C mutation in MT-TS1 in a Chinese Han family with maternally inherited nonsyndromic hearing loss. Int J Pediatr Otorhinolaryngol 2015; 79: 1654-7.
[12]
Yan X, Wang X, Wang Z, et al. Maternally transmitted late-onset non-syndromic deafness is associated with the novel heteroplasmic T12201C mutation in the mitochondrial tRNAHis gene. J Med Genet 2011; 48: 682-90.
[13]
Wang M, Liu H, Zheng J, et al. A deafness- and diabetes-associated tRNA mutation causes deficient pseudouridinylation at position 55 in tRNAGlu and mitochondrial dysfunction. J Biol Chem 2016; 291: 21029-41.
[14]
Ding Y, Xia BH, Liu Q, et al. Allele-specific PCR for detecting the deafness-associated mitochondrial 12S rRNA mutations. Gene 2016; 591: 148-52.
[15]
Tang X, Li R, Zheng J, et al. Maternally inherited hearing loss is associated with the novel mitochondrial tRNA Ser(UCN) 7505T>C mutation in a Han Chinese family. Mol Genet Metab 2010; 100: 57-64.
[16]
Moassass F, Al-Halabi B, Nweder MS, et al. Investigation of the mtDNA mutations in Syrian families with non-syndromic sensorineural hearing loss. Int J Pediatr Otorhinolaryngol 2018; 113: 110-4.
[17]
Andrews RM, Kubacka I, Chinnery PF, et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999; 23: 147.
[18]
Zhang J, Lu B, Xia WW, et al. The mitochondrial transfer RNAAsp A7551G mutation may contribute to the clinical expression of deafness associated with the A1555G mutation in a pedigree with hearing impairment. Mol Med Rep 2019; 19: 1797-802.
[19]
Ming L, Wang Y, Lu W, et al. A mutational analysis of GJB2, SLC26A4, MT-RNA1, and GJB3 in children with nonsyndromic hearing loss in the Henan province of China. Genet Test Mol Biomarkers 2019; 23: 51-6.
[20]
Adhikary B, Ghosh S, Paul S, et al. Spectrum and frequency of GJB2, GJB6 and SLC26A4 gene mutations among nonsyndromic hearing loss patients in eastern part of India. Gene 2015; 573: 239-45.
[21]
Levin L, Zhidkov I, Gurman Y, et al. Functional recurrent mutations in the human mitochondrial phylogeny: Dual roles in evolution and disease. Genome Biol Evol 2013; 5: 876-90.
[22]
Ding Y, Xia BH, Zhang CJ, et al. Mitochondrial tRNALeu(UUR) C3275T, tRNAGln T4363C and tRNALys A8343G mutations may be associated with PCOS and metabolic syndrome. Gene 2018; 642: 299-306.
[23]
Ding Y, Xia BH, Zhang CJ, et al. Mutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndrome. Am J Transl Res 2017; 9: 2984-96.
[24]
Yarham JW, Al-Dosary M, Blakely EL, et al. A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations. Hum Mutat 2011; 32: 1319-25.
[25]
Kong QP, Bandelt HJ, Sun C, et al. Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet 2006; 15: 2076-86.
[26]
Bibb MJ, Van Etten RA, Wright CT, et al. Sequence and gene organization of mouse mitochondrial DNA. Cell 1981; 26: 167-80.
[27]
Gadaleta G, Pepe G, De Candia G, et al. The complete nucleotide sequence of the Rattus norvegicus mitochondrial genome: cryptic signals revealed by comparative analysis between vertebrates. J Mol Evol 1989; 28: 497-516.
[28]
Roe BA, Ma DP, Wilson RK, et al. The complete nucleotide sequence of the Xenopus laevis mitochondrial genome. J Biol Chem 1985; 260: 9759-74.
[29]
Suzuki T, Nagao A, Suzuki T. Human mitochondrial tRNAs: biogenesis, function, structural aspects, and diseases. Annu Rev Genet 2011; 45: 299-329.
[30]
Pütz J, Dupuis B, Sissler M, et al. Mamit-tRNA, a database of mammalian mitochondrial tRNA primary and secondary structures. RNA 2007; 13: 1184-90.
[31]
Wang X, Lu J, Zhu Y, et al. Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families. Pharmacogenet Genomics 2008; 18: 1059-70.
[32]
Rybalka E, Timpani CA, Cooke MB, et al. Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency. PLoS One 2014; 9: e115763.
[33]
Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014; 94: 909-50.
[34]
Mimaki M, Ikota A, Sato A, et al. A double mutation (G11778A and G12192A) in mitochondrial DNA associated with Leber’s hereditary optic neuropathy and cardiomyopathy. J Hum Genet 2003; 48: 47-50.
[35]
Ueda T, Yotsumoto Y, Ikeda K, et al. The T-loop region of animal mitochondrial tRNA(Ser)(AGY) is a main recognition site for homologous seryl-tRNA synthetase. Nucleic Acids Res 1992; 20: 2217-22.
[36]
Meng F, He Z, Tang X, et al. Contribution of the tRNAIle 4317A→G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A→G mutation. J Biol Chem 2018; 293: 3321-34.
[37]
Valente L, Piga D, Lamantea E, et al. Identification of novel mutations in five patients with mitochondrial encephalo-myopathy. Biochim Biophys Acta 2009; 1787: 491-501.
[38]
Zhang J, Ji Y, Liu X, et al. Leber’s hereditary optic neuro-pathy caused by a mutation in mitochondrial tRNAThr in eight Chinese pedigrees. Mitochondrion 2018; 42: 84-91.
[39]
Jia Z, Wang X, Qin Y, et al. Coronary heart disease is associated with a mutation in mitochondrial tRNA. Hum Mol Genet 2013; 22: 4064-73.
[40]
Yano T, Nishio SY, Usami S. Deafness Gene Study Consortium Frequency of mitochondrial mutations in non-syndromic hearing loss as well as possibly responsible variants found by whole mitochondrial genome screening. J Hum Genet 2014; 59: 100-6.
[41]
Dai P, Yu F, Han B, et al. GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairment. J Transl Med 2009; 7: 26.
[42]
Li TC, Kuan YH, Ko TY, et al. Mechanism of a novel missense mutation, p.V174M, of the human connexin31 (GJB3) in causing nonsyndromic hearing loss. Biochem Cell Biol 2014; 92: 251-7.
[43]
Oh SK, Choi SY, Yu SH, et al. Evaluation of the pathogenicity of GJB3 and GJB6 variants associated with nonsyndromic hearing loss. Biochim Biophys Acta 2013; 1832: 285-91.
[44]
Meng F, Cang X, Peng Y, et al. Biochemical evidence for a nuclear modifier allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) related to mitochondrial tRNA modification in the phenotypic manifestation of deafness-associated 12S rRNA mutation. J Biol Chem 2017; 292: 2881-92.
[45]
Ying Z, Zheng J, Cai Z, et al. Mitochondrial haplogroup B increases the risk for hearing loss among the Eastern Asian pedigrees carrying 12S rRNA 1555A>G mutation. Protein Cell 2015; 6: 844-8.
[46]
Bai Y, Wang Z, Dai W, et al. A six-generation Chinese family in haplogroup B4C1C exhibits high penetrance of 1555A>G-induced hearing Loss. BMC Med Genet 2010; 11: 129.
[47]
Chen X, Nie Z, Wang F, et al. Late onset nonsyndromic hearing loss in a Dongxiang Chinese family is associated with the 593T>C variant in the mitochondrial tRNAPhe gene. Mitochondrion 2017; 35: 111-8.
[48]
Wu Y, Liang LZ, Xiao HL, et al. Hearing loss may be associated with the novel mitochondrial tRNA(Asp) A7551G mutation in a Chinese family. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2013; 48: 978-84. [Article in Chinese].
[49]
Kokotas H, Grigoriadou M, Yang L, et al. Homoplasmy of the G7444A mtDNA and heterozygosity of the GJB2 c.35delG mutations in a family with hearing loss. Int J Pediatr Otorhinolaryngol 2011; 75: 89-94.
[50]
Kamogashira T, Fujimoto C, Yamasoba T. Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss. BioMed Res Int 2015; 2015: 617207.